Evidence map›Paper›PMID 40970468›Full record

ArticleGlia2026

hiPSC-Derived Astrocytes From Individuals With Schizophrenia Induce a Dystrophic Phenotype in Microglial-Like Cells.

Pablo L Cardozo, Chia-Yi Lee, Juliana P S Lacerda, Júlia S Fahel, Pablo Trindade, Gabriela Vitória, Leonardo Chicaybam, Rafaela C Cordeiro, Isaque J S de Faria, Nathália C Silva and 9 more

Abstract read
In one paragraph

Article in Glia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Pablo L CardozoDepartment of Biochemistry and Immunology, Institute of Biological Sciences (ICB), Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
Chia-Yi LeeDepartment of Genetics, Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
Juliana P S LacerdaDepartment of Biochemistry and Immunology, Institute of Biological Sciences (ICB), Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
Júlia S FahelDepartment of Biochemistry and Immunology, Institute of Biological Sciences (ICB), Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
Pablo TrindadeD'or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.
Gabriela VitóriaD'or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.
Leonardo ChicaybamMolecular Carcinogenesis Program, Research Coordination, Instituto Nacional do Câncer (INCA), Rio de Janeiro, Brazil.
Rafaela C CordeiroDepartment of Biochemistry and Immunology, Institute of Biological Sciences (ICB), Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
Isaque J S de FariaDepartment of Biochemistry and Immunology, Institute of Biological Sciences (ICB), Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
Nathália C SilvaDepartment of Biochemistry and Immunology, Institute of Biological Sciences (ICB), Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
Yaovi M H TodjroDepartment of Biochemistry and Immunology, Institute of Biological Sciences (ICB), Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
Joana C do P MacielD'or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.
Martin H BonaminoMolecular Carcinogenesis Program, Research Coordination, Instituto Nacional do Câncer (INCA), Rio de Janeiro, Brazil.
Luciene B VieiraDepartment of Pharmacology, Institute of Biological Sciences (ICB), Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
Breno F CruzDepartment of Psychiatry, Faculty of Medicine, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
Rodrigo NicolatoDepartment of Psychiatry, Faculty of Medicine, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
Kristen J BrennandDepartment of Genetics, Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
Stevens K RehenD'or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.
Fabíola M RibeiroDepartment of Biochemistry and Immunology, Institute of Biological Sciences (ICB), Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 403171/2023-7Conselho Nacional de Desenvolvimento Científico e Tecnológico 406968/2024-1Conselho Nacional de Desenvolvimento Científico e Tecnológico 444206/2024-8Fundação de Amparo à Pesquisa do Estado de Minas Gerais APQ-00140-23Fundação de Amparo à Pesquisa do Estado de Minas Gerais APQ-03921-22Fundação de Amparo à Pesquisa do Estado de Minas Gerais BPD-00067-22
6 · The paper itself

Abstract

Neuroinflammation, particularly astrocyte reactivity, is increasingly linked to schizophrenia (SCZ). Yet, the crosstalk between astrocytes and microglia in SCZ, especially under pro-inflammatory conditions, remains unclear. Here, we employed human induced-pluripotent stem cells to compare how astrocytes from five age-matched individuals with SCZ and five neurotypical controls, upon stimulation with TNF-α, affected microglial biology. TNF-α stimulation of SCZ astrocytes, relative to their control counterparts, triggered increased mRNA expression of pro-inflammatory cytokines and CX3CL1. Interestingly, transcriptomic and gene set enrichment analyses revealed that reactive SCZ astrocytes promoted the downregulation of biological processes associated with immune cell proliferation and activation, phagocytosis, and cell migration in induced microglial-like cells (iMGs). Under such conditions, iMGs assumed a dystrophic/senescent-like phenotype, which was associated with accelerated transcriptional aging. Functional validations showed that TNF-α-stimulated SCZ astrocytes promoted reduced synaptoneurosomes phagocytosis by iMGs. Interestingly, while both reactive control and SCZ astrocytes were capable of inducing significant microglial migration in a CX3CR1-dependent manner, TNF-α-stimulated SCZ astrocytes failed to promote greater iMG chemotaxis, compared with their stimulated control counterparts, despite secreting more than twice as much CX3CL1. This was likely due to SCZ astrocytes triggering reduction in CX3CR1 plasma membrane levels in iMGs. Altogether, these findings suggest that astrocytes contribute to SCZ pathology by altering normal microglial function and inducing a dystrophic phenotype.

Indexed as

AstrocytesInduced Pluripotent Stem CellsMicrogliaSchizophreniaAdultCell MovementCells, CulturedChemokine CX3CL1CX3C Chemokine Receptor 1FemaleHumansMalePhagocytosisPhenotypeTumor Necrosis Factor-alphaChemokine CX3CL1CX3C Chemokine Receptor 1Tumor Necrosis Factor-alphaastrocytesCX3CL1CX3CR1dystrophicmicrogliaschizophrenia

Identifiers

PMID40970468
PMCPMC12666992

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.